Marker Therapeutics Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Marker Therapeutics Inc.
Former names
Tapimmune INC. Genemax Corp Eduverse COM
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Houston
Headquarters state / province
Texas
Headquarters country
United States
Fiscal year end
December
Ticker symbol
MRKR
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001094038
EIN
88-0277072

Board of directors

Follow this board

Chief executives

Juan Vera · President and CEO
Dates unknown

Director election results

Annual meeting of May 1, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 5 other boards.

Network of Marker Therapeutics Inc.'s board connections ADMA Biologics Inc ADMA Biologics Inc Kalaris Therapeutics Inc. Kalaris Therapeutics I... Korro Bio Inc. Korro Bio Inc. Matinas Biopharma Holdings Inc. Matinas Biopharma Hold... Pliant Therapeutics Inc. Pliant Therapeutics In... Juan Vera Juan Vera Katharine Knobil Katharine Knobil Kathryn Penkus Corzo Kathryn Penkus Corzo Steve Elms Steve Elms Marker Therapeutics Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Dec 23, 2024 Steve Elms Director Open-market purchase +11,085 $3.20 $35,472
Dec 23, 2024 NEA Partners 16, L.P. 10% owner Open-market purchase +554,250 $3.20 $1,773,600
Mar 25, 2021 Norman David Eansor Director Gift −14,285 — —
Mar 25, 2021 Norman David Eansor Director Gift +7,142 — —
Mar 25, 2021 Norman David Eansor Director Gift +7,142 — —
Mar 16, 2021 Norman David Eansor Director Open-market purchase +14,285 $17.50 $249,988

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.